Chrogene Aarogyam Biotech Pvt Ltd is a startup from India that focuses on innovating healthcare products. The company was incorporated in October 2017 under the Companies Act, 2013. Here is a look into its foundation story, vision, and the background of its founding team.
The company's vision is clear: to make healthcare more accessible and affordable, especially for people in the Indian subcontinent. The mantra "Healthcare for all" drives their mission to innovate and provide quality healthcare products. From its early days, Chrogene Aarogyam has been working towards addressing the unmet needs in both domestic and global markets[1][2][3].
In its initial stages, the company focused on building partnerships with institutions of excellence to leverage their vast potential. This strategic approach has been crucial in their growth and development. The company has also been recognized as a startup by the Department of Industrial Policy and Promotion (DIPP), which has further boosted their credibility and support[1].
The founding team of Chrogene Aarogyam Biotech Pvt Ltd is led by Karthick, who has a strong educational background. Karthick completed his B.Tech in Chemical Engineering from IIT-Madras in 2014, followed by an MS in Nanotechnology from the University of Pennsylvania in 2016, and another MS in Chemical Engineering from the Georgia Institute of Technology in 2018. His research experience includes working on the application of Filomicelle Nanoparticles for Cancer Drug Delivery, which was awarded a prestigious research grant[1].
Before starting Chrogene Aarogyam, Karthick worked in various roles, including engineering projects in a nutraceutical manufacturing company and as a sales associate in a logistics firm. This diverse experience has equipped him with the necessary skills to drive the company forward. Other key members of the board include Poongothai Ayepalayam Ramaswamy, Ramaswamy Perianna Ayyapalayam, and Tamilmani Shanmugam[2].
Since its inception, Chrogene Aarogyam Biotech Pvt Ltd has undergone significant evolution. Here’s a look at how the company has grown from its initial concept to its current state, along with key milestones and product portfolio expansion.
The initial concept of Chrogene Aarogyam was to innovate healthcare products that could address unmet needs. Over time, the company has expanded its focus to include research and development in various healthcare areas, such as blood-related disorders, nanotechnology, and old age diseases. This broadened scope has helped the company to stay relevant and innovative in the healthcare sector[2].
The company’s current state is marked by active involvement in conducting workshops and skill development programs for the life sciences, pharmaceutical, and biotechnology sectors. This approach not only enhances their own capabilities but also contributes to the broader industry by sharing knowledge and skills[1].
Chrogene Aarogyam Biotech Pvt Ltd has achieved several key milestones since its founding. One notable milestone is the funding received for their project "NON-INVASIVE POINT OF CARE DIAGNOSTICS FOR SICKLE CELL DISEASE" from BIRAC-BIG. This funding has been instrumental in advancing their research and development efforts[1].
Here are some key milestones:
Chrogene Aarogyam Biotech Pvt Ltd has expanded its product portfolio significantly. The company now deals with a range of healthcare products, including those related to blood disorders, nanotechnology, and old age diseases. Here are some areas where they have expanded their product portfolio:
- Blood-related disorders: The company is working on diagnostics and treatments for blood-related disorders, such as sickle cell disease.
The technology infrastructure of Chrogene Aarogyam Biotech Pvt Ltd is crucial for its innovative work in the healthcare sector. Here’s an overview of their core platform architecture, security and compliance framework, and their innovative contributions to the industry.
The core platform architecture of Chrogene Aarogyam Biotech Pvt Ltd is designed to support their research and development activities. The company uses advanced technologies such as nanotechnology and molecular diagnostics to develop their products. Their platform is flexible and adaptable, allowing for continuous innovation and improvement[1].
Here are some key components of their platform architecture:
Chrogene Aarogyam Biotech Pvt Ltd adheres to a strict security and compliance framework to ensure the integrity and safety of their products. This includes compliance with regulatory standards and maintaining confidentiality of patient data.
Here are some aspects of their security and compliance framework:
Chrogene Aarogyam Biotech Pvt Ltd is at the forefront of innovation in the healthcare industry. Their work in non-invasive point of care diagnostics and nanotechnology is particularly noteworthy.
Here are some innovative contributions:
Chrogene Aarogyam Biotech Pvt Ltd has made a significant impact in the healthcare market, particularly in India. The company focuses on innovating affordable and high-quality healthcare products, making them accessible to a wider population. Here’s how they are making a difference:
The company's user base has been growing steadily due to its innovative products and services. One of the key factors is their project on "NON-INVASIVE POINT OF CARE DIAGNOSTICS FOR SICKLE CELL DISEASE," which has received funding from BIRAC-BIG. This project aims to provide diagnostic solutions that are easy to use and accessible, especially in rural areas.
The user base growth is also driven by the company's commitment to conducting workshops and skill development programs for the life science, pharmaceutical, and biotechnology sectors. These programs help in spreading awareness and educating professionals about the latest advancements in healthcare technology.
Additionally, the company's partnership with institutions of excellence helps in leveraging the vast potential available, which in turn contributes to the growth of their user base. This collaborative approach ensures that their products are validated and trusted by a wider audience[6]).
Chrogene Aarogyam Biotech has been expanding its market share by addressing the unmet needs of both domestic and global markets. The company's mission to make healthcare more accessible and affordable resonates well with the Indian subcontinent, where there is a high demand for such products[6]).
Their market share expansion is also facilitated by their strategic partnerships. For instance, collaborating with institutions and industries helps them to innovate and bring new products to the market quickly. This approach enables them to stay ahead in the competitive biotech industry[6]).
Here are some key areas where they are expanding their market share:
Chrogene Aarogyam Biotech is committed to financial inclusion by making healthcare products affordable. Their vision of "Healthcare for all" is reflected in their pricing strategies and distribution channels. Here’s how they are achieving this:
The company ensures that their products are priced affordably, making them accessible to a broader segment of the population. This is particularly important in a country like India where a significant portion of the population has limited financial resources[6]).
Additionally, they are involved in various initiatives that help in reducing the financial burden on patients. For example, their diagnostic solutions are designed to be cost-effective, reducing the need for expensive hospital visits and treatments.
Chrogene Aarogyam Biotech Pvt Ltd has had a notable financial journey since its inception in 2017. Here’s an overview of their financial growth and milestones:
The company has seen significant revenue growth, driven by their innovative products and strategic partnerships. Although specific revenue figures for recent years are not provided, their financial statements up until 2023 show a positive trend. For instance, in FY 2020, the company reported a notable profit percentage, indicating strong financial performance[9]).
The revenue growth is also attributed to their successful projects, such as the non-invasive point-of-care diagnostics for sickle cell disease, which received funding. Such projects not only generate revenue but also enhance the company's reputation and market presence[6]).
Here are some key financial indicators:
Chrogene Aarogyam Biotech has been on a path to profitability since its inception. The company's focus on innovation and affordability has helped in achieving financial stability. Here’s how they have managed to stay profitable:
The company's approach to validating healthcare products through a team effort ensures that their products meet high standards, reducing the risk of financial losses. This meticulous validation process helps in maintaining profitability[6]).
Additionally, their involvement in conducting workshops and skill development programs generates additional revenue streams, contributing to their overall profitability.
Chrogene Aarogyam Biotech has received significant investments, particularly for their innovative projects. Here’s an overview of their investment rounds and valuations:
The company received funding from BIRAC-BIG for their project on non-invasive point-of-care diagnostics for sickle cell disease. This funding is a testament to the potential and value of their innovative projects[6]).
Although specific valuation figures are not provided, the company's authorized and paid-up capital indicate a stable financial foundation. The company has an authorized capital and paid-up capital of ₹0.10 M each, as per the Ministry of Corporate Affairs records[9]).
Chrogene Aarogyam Biotech Pvt Ltd has formed several strategic partnerships to drive innovation and growth. Here are some of the key partnerships they have established:
Although specific details on banking collaborations are not available, the company's involvement in various financial initiatives suggests that they may have partnerships with financial institutions to support their operations. Here’s how such partnerships could benefit them:
Banking collaborations can provide the necessary financial support for their innovative projects. This could include loans, grants, or other financial instruments that help in funding research and development activities.
Chrogene Aarogyam Biotech has likely formed partnerships with merchants and distributors to ensure the widespread availability of their products. Here’s how these partnerships benefit the company:
Merchant partnerships help in distributing their products to a broader audience. This is particularly important for healthcare products that need to reach remote and underserved areas.
These partnerships also help in reducing distribution costs and ensuring that products are available at the right time and place.
The company has formed technology alliances to enhance their innovation capabilities. Here’s how these alliances benefit them:
Technology alliances with institutions and industries help in leveraging the latest advancements in biotechnology. For example, their collaboration with institutions of excellence enables them to develop innovative diagnostic solutions[6]).
These alliances also provide access to advanced research facilities and expertise, which is crucial for developing high-quality healthcare products.
Explore our expert-led programs or join our free community of 5,000+ Indian founders - scale with 18startup!
Get started 🚀 Antah Prerna Education Private Limited,
Office Address: 55, Raju Naidu Road, Tatabad, Coimbatore – 641012